Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Nov 18;6(1):58.
doi: 10.1186/s41747-022-00312-x.

Algebraic topology-based machine learning using MRI predicts outcomes in primary sclerosing cholangitis

Affiliations
Multicenter Study

Algebraic topology-based machine learning using MRI predicts outcomes in primary sclerosing cholangitis

Yashbir Singh et al. Eur Radiol Exp. .

Abstract

Background: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease that can lead to cirrhosis and hepatic decompensation. However, predicting future outcomes in patients with PSC is challenging. Our aim was to extract magnetic resonance imaging (MRI) features that predict the development of hepatic decompensation by applying algebraic topology-based machine learning (ML).

Methods: We conducted a retrospective multicenter study among adults with large duct PSC who underwent MRI. A topological data analysis-inspired nonlinear framework was used to predict the risk of hepatic decompensation, which was motivated by algebraic topology theory-based ML. The topological representations (persistence images) were employed as input for classification to predict who developed early hepatic decompensation within one year after their baseline MRI.

Results: We reviewed 590 patients; 298 were excluded due to poor image quality or inadequate liver coverage, leaving 292 potentially eligible subjects, of which 169 subjects were included in the study. We trained our model using contrast-enhanced delayed phase T1-weighted images on a single center derivation cohort consisting of 54 patients (hepatic decompensation, n = 21; no hepatic decompensation, n = 33) and a multicenter independent validation cohort of 115 individuals (hepatic decompensation, n = 31; no hepatic decompensation, n = 84). When our model was applied in the independent validation cohort, it remained predictive of early hepatic decompensation (area under the receiver operating characteristic curve = 0.84).

Conclusions: Algebraic topology-based ML is a methodological approach that can predict outcomes in patients with PSC and has the potential for application in other chronic liver diseases.

Keywords: Algorithm; Cholangitis (Sclerosing); Liver cirrhosis; Machine learning; Magnetic resonance imaging.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Workflow of algebraic topology-based machine learning with imaging signal as input
Fig. 2
Fig. 2
A barcode representation of hepatic decompensation status within a year. The horizontal axis line corresponds to the parameter ɛ, and the vertical axis line is the ordering of the homology generators. Note that the vertical placement is only introduced for display and does not have any intrinsic meaning. a Patients with hepatic decompensation within a year group exhibit Betti numbers typically between 0 and 50. b Patients without hepatic decompensation exhibit Betti numbers between 0 and 100. With the red box-based indicator, we can see a clear difference between the 1-dimensional homologies durations in both categories
Fig. 3
Fig. 3
A persistence image representation of hepatic decompensation within a year. Persistence image is showing topologic data analysis stable vectorization for both (a) patients developing hepatic decompensation within a year and (b) patients not developing hepatic decompensation within a year
Fig. 4
Fig. 4
Receiver operating characteristic curve for validation data

References

    1. Eaton JE, Talwalkar JA, Lazaridis KN, et al. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology. 2013;145:521–536. doi: 10.1053/j.gastro.2013.06.052. - DOI - PMC - PubMed
    1. Ponsioen CY, Chapman RW, Chazouillères O, et al. Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an International PSC Study Group consensus process. Hepatology. 2016;63:1357–1367. doi: 10.1002/hep.28256. - DOI - PubMed
    1. Mazhar A, Russo MW. Systematic review: non-invasive prognostic tests for primary sclerosing cholangitis. Aliment Pharmacol Ther. 2021;53:774–783. doi: 10.1111/apt.16296. - DOI - PubMed
    1. Schramm C, Eaton J, Ringe KI, et al. Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group. Hepatology. 2017;66:1675–1688. doi: 10.1002/hep.29293. - DOI - PubMed
    1. Ruiz A, Lemoinne S, Carrat F, et al. Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology. 2014;59:242–250. doi: 10.1002/hep.26620. - DOI - PubMed

Publication types

LinkOut - more resources